Theranostic liposomes loaded with quantum dots and apomorphine for brain targeting and bioimaging

International Journal of Nanomedicine

Volumn 7, Issue , 2012, Pages 1599-1611

  Wen, Chih Jen ^a   Zhang, Li Wen ^b   Al Suwayeh, Saleh A ^c   Yen, Tzu Chen ^a   Fang, Jia You ^b,d  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

^d CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

Author keywords

Apomorphine; Bioimaging; Brain targeting; Liposomes; Quantum dots

Indexed keywords

APOMORPHINE; CLATHRIN; LIPOSOME; QUANTUM DOT; THERANOSTIC LIPOSOME; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; DRUG CARRIER; NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BILAYER MEMBRANE; BLOOD BRAIN BARRIER; CAVEOLA; CELL IMMORTALIZATION; CELL TRANSPORT; CONTROLLED STUDY; DRUG DISTRIBUTION; ENCAPSULATION; ENDOCYTOSIS; EX VIVO STUDY; FEMALE; IN VIVO STUDY; MOUSE; NEUROIMAGING; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY; STRUCTURE ANALYSIS; TISSUE DISTRIBUTION; TRANSMISSION ELECTRON MICROSCOPY; ANIMAL; BRAIN; CELL LINE; CHEMISTRY; FLUORESCENCE MICROSCOPY; METABOLISM; METHODOLOGY; NANOMEDICINE; NUDE MOUSE; ULTRASTRUCTURE;

ANIMALS; APOMORPHINE; BRAIN; CELL LINE; DRUG CARRIERS; ENDOCYTOSIS; FEMALE; LIPOSOMES; MICE; MICE, NUDE; MICROSCOPY, FLUORESCENCE; NANOMEDICINE; NANOPARTICLES; NEUROIMAGING; PARTICLE SIZE; QUANTUM DOTS;

EID: 84866768946     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S29369     Document Type: Article

References (39)

1. Wilson B, Samanta MK, Santhi K, Kumar KP, Paramakrishnan N, Suresh B. Poly(n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer's disease. Brain Res. 2008;1200:159-168.
2. 2 agonist. Life Sci. 2007;80(17): 1564-1571.
3. Fenske DB, Cullis PR. Liposomal nanomedicines. Expert Opin Drug Deliv. 2008;5(1):25-44.
4. Wang C, Gao X, Su X. In vitro and in vivo imaging with quantum dots. Anal Bioanal Chem. 2010;397(4):1397-1415.
5. Ozkan M. Quantum dots and other nanoparticles: what can they offer to drug discovery? Drug Discover Today. 2004;9(24):1065-1071.
6. Yang H. Nanoparticle-mediated brain-specific drug delivery, imaging, and diagnosis. Pharm Res. 2010;27(9):1759-1771.
7. Antonini A, Isaias IU, Rodolfi G, et al. A 5-year prospective assessment of advanced Parkinson disease patients treated with subcutaneous apomorphine infusion or deep brain stimulation. J Neurol. 2011; 258(4):579-585.
8. Hwang TL, Lin YK, Chi CH, Huang TH, Fang JY. Development and evaluation of perfluorocarbon nanobubbles for apomorphine delivery. J Pharm Sci. 2009;98(10):3735-3747.
9. Brown RC, Morris AP, O'Neil RG. Tight junction protein expression and barrier properties of immortalized mouse brain microvessel endothelial cells. Brain Res. 2007;1130(1):17-30.
10. Yuan W, Li G, Fu BM. Effect of surface charge of immortalized mouse cerebral endothelial cell monolayer on transport of charged solutes. Ann Biomed Engin. 2010;38(4):1463-1472.
11. Tosi G, Costantino L, Ruozi B, Forni F, Vandelli MA. Polymeric nanoparticles for the drug delivery to the central nervous system. Expert Opin Drug Deliv. 2008;5(2):155-174.
12. Sigot V, Arndt-Jovin DJ, Jovin TM. Targeted cellular delivery of quantum dots loaded on and in biotinylated liposomes. Bioconjug Chem. 2010;21(8):1465-1472.
13. Wang Y, Chen L. Quantum dots, lighting up the research and development of nanomedicine. Nanomedicine. 2011;7(4):385-402.
14. Al-Jamal WT, Kostarelos K. Liposomes: from a clinically established drug delivery system to a nanoparticle platform for theranostic nanomedicine. Acc Chem Res. 2011;44(10):1094-1104.
15. Fang JY, Fang CL, Liu CH, Su YH. Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC). Eur J Pharm Biopharm. 2008; 70(2):633-640.
16. Al-Jamal WT, Al-Jamal KT, Cakebread A, Halket JM, Kostarelos K. Blood circulation and tissue biodistribution of lipid-quantum dot (L-QD) hybrid vesicles intravenously administered in mice. Bioconjug Chem. 2009;20(9):1696-1702.
17. le Masne de Chermont Q, Chaneac C, Seguin J, et al. Nanoprobes with near-infrared persistent luminescence for in vivo imaging. Proc Natl Acad Sci U S A. 2007;104(22):9266-9271.
18. Vibin M, Vinayakan R, John A, Raji V, Rejiya CS, Abraham A. Biokinetics and in vivo distribution behaviours of silica-coated cadmium selenide quantum dots. Biol Trace Elem Res. 2011;142(2):213-222.
19. Arnold RD, Mager DE, Slack JE, Straubinger RM. Effect of repetitive administration of doxorubicin-containing liposomes on plasma pharmacokinetics and drug biodistribution in a rat brain tumor model. Clin Cancer Res. 2005;11(24 Pt 1):8856-8865.
20. Ely DR, Carvajal MT. Determination of the scale of segregation of low dose tablets using hyperspectral imaging. Int J Pharm. 2011; 414(1-2):157-160.
21. Franch-Lage F, Amigo JM, Skibsted E, Maspoch S, Coello J. Fast assessment of the surface distribution of API and excipients in tablets using NIR-hyperspectral imaging. Int J Pharm. 2011;411(1-2):27-35.
22. Picada JN, Maris AF, Ckless K, Salvador M, Khromov-Borisov NN, Henriques JA. Differential mutagenic, antimutagenic and cytotoxic responses induced by apomorphine and its oxidation product, 8-oxo-apomorphine-semiquinone, in bacteria and yeast. Mutat Res. 2003;539(1-2):29-41.
23. Maysinger D, Behrendt M, Lalancette-Hébert M, Kriz J. Real-time imaging of astrocyte response to quantum dots: in vivo screening model system for biocompatibility of nanoparticles. Nano Lett. 2007; 7(8):2513-2520.
24. Ghaderi S, Ramesh B, Seifalian AM. Fluorescence nanoparticles "quantum dots" as drug delivery system and their toxicity: a review. J Drug Target. 2011;19(7):475-486.
25. Xie Y, Ye L, Zhang X, et al. Transport of nerve growth factor encapsulated into liposomes across the blood-brain barrier: in vitro and in vivo studies. J Control Release. 2005;105(1-2):106-119.
26. Lockman PR, Oyewumi MO, Koziara JM, Roder KE, Mumper RJ, Allen DD. Brain uptake of thiamine-coated nanoparticles. J Control Release. 2003;93(3):271-282.
27. Schnyder A, Huwyler J. Drug transport to brain with targeted liposomes. NeuroRx. 2005;2(1):99-107.
28. Clarke SJ, Hollmann CA, Zhang Z, et al. Photophysics of dopaminemodified quantum dots and effects on biological systems. Nat Mater. 2006;5(5):409-417.
29. Ishiguro N, Nozawa T, Tsujihata A, et al. Influx and efflux transport of H1-antagonist epinastine across the blood-brain barrier. Drug Metab Dispos. 2004;32(5):519-524.
30. Lu W, Sun Q, Wan J, She Z, Jiang XG. Cationic albumin-conjugated pegylated nanoparticles allow gene delivery into brain tumors via intravenous administration. Cancer Res. 2006;66(24):11878-11887.
31. Voura EB, Jaiswal JK, Mattoussi H, Simon SM. Tracking metastatic tumor cell extravasation with quantum dot nanocrystals and fluorescence emission-scanning microscopy. Nat Med. 2004;10(9):993-998.
32. Medintz IL, Uyeda HT, Goldman ER, Mattoussi H. Quantum dot bioconjugates for imaging, labeling and sensing. Nat Mater. 2005;4(6): 435-446.
33. Kim JS, Cho KJ, Tran TH, et al. In vivo NIR imaging with CdTe/CdSe quantum dots entrapped in PLGA nanospheres. J Colloid Interface Sci. 2011;353(2):363-371.
34. Taylor CJ, Nicola PA, Wang S, Barrand MA, Hladky SB. Transporters involved in regulation of intracellular pH in primary cultured rat brain endothelial cells. J Physiol. 2006;576(Pt 3):769-785.
35. Jain KK. Nanobiotechnology-based drug delivery to the central nervous system. Neurodegener Dis. 2007;4(4):287-291.
36. Kim HR, Gil S, Andrieux K, et al. Low-density lipoprotein-mediated endocytosis of PEGylated nanoparticles in rat brain endothelial cells. Cell Mol Life Sci. 2007;64(3):356-364.
37. Maxfield FR, McGraw TE. Endocytic recycling. Nat Rev Mol Cell Biol. 2004;5(2):121-132.
38. Wang Z, Tiruppathi C, Minshall RD, Malik AB. Size and dynamics of caveolae studied using nanoparticles in living endothelial cells. ACS Nano. 2009;3(12):4110-4116.
39. Koivusalo M, Welch C, Hayashi H, et al. Amiloride inhibits macropinocytosis by lowering submembranous pH and preventing Rac1 and Cdc42 signaling. J Cell Biol. 2010;188(4):547-563.